Evidence map›Paper›PMID 36998737›Full record

ArticleFrontiers in neuroscience2023

Oxytocin receptors in the Magel2 mouse model of autism: Specific region, age, sex and oxytocin treatment effects.

Valentina Gigliucci, Marta Busnelli, Francesca Santini, Camilla Paolini, Alessandra Bertoni, Fabienne Schaller, Françoise Muscatelli, Bice Chini

Open access · goldFull text read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. MAGEL2 (patho-)physiology and Schaaf-Yang syndrome.Developmental medicine and child neurology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Imprinting disorders.Nature reviews. Disease primers · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Valentina GigliucciInstitute of Neuroscience, National Research Council, Vedano al Lambro, Italy.
Marta BusnelliInstitute of Neuroscience, National Research Council, Vedano al Lambro, Italy.
Francesca SantiniInstitute of Neuroscience, National Research Council, Vedano al Lambro, Italy.
Camilla PaoliniInstitute of Neuroscience, National Research Council, Vedano al Lambro, Italy.
Alessandra BertoniAix Marseille University, INSERM, INMED, Marseille, France.
Fabienne SchallerAix Marseille University, INSERM, INMED, Marseille, France.
Françoise MuscatelliAix Marseille University, INSERM, INMED, Marseille, France.
Bice ChiniInstitute of Neuroscience, National Research Council, Vedano al Lambro, Italy.
University of Milano-Bicocca · ITInserm · FRNational Research Council · ITInstitut de Neurobiologie de la Méditerranée · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neurohormone oxytocin (OXT) has been implicated in the regulation of social behavior and is intensively investigated as a potential therapeutic treatment in neurodevelopmental disorders characterized by social deficits. In the

Indexed as

neurodevelopmental disorders (NDD)oxytocin receptor expressionpostnatal oxytocin treatmentPrader-Willi Syndrome (PWS)Schaaf-Yang Syndrome

Identifiers

PMID36998737
PMCPMC10043208
OpenAlexW4324145372

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read19
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.